BEDRIYE TOMBULOGLU, MD
Clinical Pathology/Laboratory Medicine Physician in GREENFIELD, Wisconsin. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
BEDRIYE TOMBULOGLU, MD filed 536 Medicare Part D claims in 2023 as a Clinical Pathology/Laboratory Medicine Physician in GREENFIELD, Wisconsin, prescribing 84% generic.
- 536
- Part D claims, 2023
- 84%
- generic prescribing
- $61.7
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
BEDRIYE TOMBULOGLU, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
536 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
BEDRIYE TOMBULOGLU, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about BEDRIYE TOMBULOGLU, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Wisconsin
How Clinical Pathology/Laboratory Medicine Physician compares to other specialties among Wisconsin providers
Clinical Pathology/Laboratory Medicine Physician share within Wisconsin
Clinical Pathology/Laboratory Medicine Physician is one of the more visible NUCC categories in Wisconsin
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Clinical Pathology/Laboratory Medicine Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Clinical Pathology/Laboratory Medicine Physician ABMS/AOA estimate
Est. board-certified rate (Clinical Pathology/Laboratory Medicine Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Clinical Pathology/Laboratory Medicine Physician US NPIs
Specialty board-certified rate — Clinical Pathology/Laboratory Medicine Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
BEDRIYE TOMBULOGLU, MD appears in the CMS NPPES registry as a Clinical Pathology/Laboratory Medicine Physician provider holding MD credentials at 4325 S 60TH ST, GREENFIELD, WI, 53220, with a listed phone of (414) 545-5500. NPI 1811083009 was issued on 10/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TOMBULOGLU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 536 prescription claims written by this provider, covering 67 Medicare beneficiaries and totaling roughly $53K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 2.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Clinical Pathology/Laboratory Medicine Physician is a narrow specialty nationwide, with 1,229 enrolled providers across 51 states and an average of 149 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1811083009 |
|---|---|
| Specialty | Clinical Pathology/Laboratory Medicine Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 10/05/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm BEDRIYE TOMBULOGLU, MD's current license status, disciplinary history, and board certifications with the Wisconsin Department of Safety and Professional Services in Wisconsin before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BEDRIYE TOMBULOGLU, MD. Source: openpaymentsdata.cms.gov.
Total received
$62
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 536 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,117
- Total Day Supply
- 30,116
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $37K
- Generic Drug Cost
- $16K
- Opioid Claims
- 13 (2.4% rate)
- Antibiotic Claims
- 87
Patient Demographics
- Average Patient Age
- 70.3 years
- Avg HCC Risk Score
- 0.90
- Gender Split
- 67% female / 33% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What BEDRIYE TOMBULOGLU, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Irbesartan
Irbesartan
29 claims
- Pravastatin Sodium
Pravastatin Sodium
24 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
20 claims
- Amoxicillin-Clavul…
Amoxicillin-Clavulanate Potass
20 claims
- Metformin Hcl
Metformin Hcl
20 claims
- Allopurinol
Allopurinol
19 claims
- Azithromycin
Azithromycin
18 claims
- Diltiazem 24hr Er
Diltiazem 24hr Er
14 claims
| Drug | Claims |
|---|---|
| Irbesartan | 29 |
| Pravastatin Sodium | 24 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 20 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 20 |
| Metformin Hcl | 20 |
| Allopurinol | 19 |
| Azithromycin | 18 |
| Diltiazem 24hr Er Diltiazem Hcl | 14 |
| Levothyroxine Sodium | 14 |
| Losartan Potassium | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Clinical Pathology/Laboratory Medicine Physician Overview
How BEDRIYE TOMBULOGLU, MD fits within the Clinical Pathology/Laboratory Medicine Physician landscape nationally.
BEDRIYE TOMBULOGLU, MD's 536 claims are above the specialty average of 149.
Nearby Clinical Pathology/Laboratory Medicine Physician Providers in Wisconsin
Other clinicians with the same primary specialty enrolled in Wisconsin, drawn from the same CMS NPPES roster as TOMBULOGLU.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Wisconsin
Frequently Asked Questions
What is BEDRIYE TOMBULOGLU, MD's specialty? ▼
How much does BEDRIYE TOMBULOGLU, MD prescribe under Medicare Part D? ▼
Where is BEDRIYE TOMBULOGLU, MD located? ▼
What is BEDRIYE TOMBULOGLU, MD's NPI number? ▼
Does BEDRIYE TOMBULOGLU, MD prescribe more brand-name or generic drugs? ▼
Does BEDRIYE TOMBULOGLU, MD prescribe opioids? ▼
How many Clinical Pathology/Laboratory Medicine Physician providers are there in the US? ▼
What drugs does BEDRIYE TOMBULOGLU, MD prescribe most often? ▼
Does BEDRIYE TOMBULOGLU, MD accept Medicare? ▼
How can I verify BEDRIYE TOMBULOGLU, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology